Shared Perspectives

I have 0 Questions View all

  • After learning they or someone they love was diagnosed with partial-onset seizures, these Advocates learned to cope with epilepsy in their lives. Some even learned how strong they and their families could be when facing a challenge together. Now they share the perspective they've gained with you. Select videos by Advocate or topic.

  • On caregiving: When the person you love has epilepsy, you play a very special role.

  • Topic 10 Intro content. Topic 10 Intro content. Topic 10 Intro content. Topic 10 Intro content.

  • On finding and working with the right doctor: You and your doctor should be partners in your treatment plan.

  • On living independently: There are many levels of independence. Learn more about the experiences of these Advocates.

  • On parenthood: Tips for handling parenting when you have partial-onset seizures.

  • Topic 12 Intro content. Topic 12 Intro content. Topic 12 Intro content. Topic 12 Intro content.

  • On pursuing career and school goals: A little extra communication can help teachers and employers understand your needs.

  • On reflections on dating and marriage: Honesty about your epilepsy is the first step in a meaningful relationship.

  • On views on treatment and not settling: Be an active participant in the treatment of your partial-onset seizures.

  • Alan Avid fisherman and guitarist

     
  • Heather Ardent hiker and
    kayaker

     
  • Loretta Green-thumb gardener, sons have epilepsy

     
  • LuAnn Serious choir singer

     
  • Mark Gung-ho grandfather

     
  • Jesse Married over 25 years,
    wife has epilepsy

     
  • Raymond Enthusiastic Bible
    college student

     
  • Rick Old-home renovator

     
  • Veronica Dedicated traveler

     
Clear selection and view all Advocates Read Advocates' in-depth personal stories
Indication

Vimpat® (lacosamide) is a prescription medicine that is used with other medicines to treat partial-onset seizures in people 17 years of age and older with epilepsy.

Important Safety Information

Vimpat is generally well-tolerated, but may not be for everyone. Ask your healthcare provider if Vimpat is right for you.

Warnings and Precautions

Antiepileptic drugs, including Vimpat, may cause suicidal thoughts or actions in a very small number of people, about 1 in 500. Call your healthcare provider right away if you have new or worsening symptoms of depression, any unusual changes in mood or behavior, or suicidal thoughts, behavior, or thoughts about self harm that you have never had before or may be worse than before. Do not stop taking Vimpat without first talking to your healthcare provider. Stopping Vimpat suddenly can cause serious problems.

Vimpat may also cause you to feel dizzy, have double vision, feel sleepy, or have problems with coordination and walking. You should not drive, operate machinery or do other dangerous activities until you know how Vimpat affects you.

Vimpat may cause you to have an irregular heartbeat or may cause you to feel faint. Call your healthcare provider if you have a fast, slow, or pounding heartbeat, shortness of breath, feel lightheaded, or if you fainted or feel like you are going to faint.

Vimpat is classified as a federally controlled substance (C-V) due to a low potential for abuse. Keep your Vimpat in a safe place and do not give it to anyone else.

In rare cases, Vimpat may cause a serious allergic reaction that may affect your skin or other parts of your body such as your liver or blood cells. Call your healthcare provider right away if you have a skin rash or hives, fever or swollen glands that do not go away, shortness of breath, swelling of the legs, yellowing of the skin or whites of the eyes, or dark urine.

Vimpat oral solution contains aspartame, a source of phenylalanine.

Common Adverse Reactions

The most common side effects with Vimpat are dizziness, headache, nausea, and double vision. To report Suspected Adverse Reactions, contact UCB, Inc. at 866-822-0068 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.

Please see additional patient information in the Patient Medication Guide. This information does not take the place of talking with your healthcare provider about your condition or your treatment.